Lemaitre Vascular (LMAT) Non-Current Debt (2020 - 2021)
Lemaitre Vascular's (LMAT) quarterly Non-Current Debt came in at $22.4 million in Q2 2021, down 39.31% year-on-year from $37.0 million in Q2 2020, and down 21.19% on a QoQ basis from $28.5 million in Q1 2021.
Lemaitre Vascular (LMAT) Non-Current Debt (2020 - 2021) Analysis & Trends
Lemaitre Vascular (LMAT) has 2 years of Non-Current Debt data on file, last reported at $22.4 million in Q2 2021.
- On a quarterly basis, Non-Current Debt fell 39.31% year-over-year to $22.4 million in Q2 2021; TTM through Jun 2021 was $22.4 million, a 39.31% decrease from a year earlier, with the FY2020 full-year figure at $35.5 million, changed N/A from the prior year.
- Non-Current Debt for Q2 2021 stood at $22.4 million, down from $28.5 million in the prior quarter.
- Over the last five years, Non-Current Debt for LMAT reached as high as $37.0 million in Q2 2020 and fell as low as $22.4 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 4.16 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 14.71 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 12.50 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 404.17 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.86 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.58 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 22.45 Mn |
| Mar 31, 2021 | 28.49 Mn |
| Dec 31, 2020 | 35.53 Mn |
| Sep 30, 2020 | 36.23 Mn |
| Jun 30, 2020 | 36.99 Mn |